Virginia Commonwealth University
Richmond, Virginia, 23298, United States
NCT Number: NCT01853007
The purpose of this study is to test the impact of a newly developed educational program on kidney transplant candidates' communication about living and deceased donor kidney transplantation.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Richmond, Virginia, 23298, United States
The Communicating about Choices (COACH) in Transplantation program educates patients with end stage renal disease, who are waitlisted for kidney transplantation, about kidney disease and the risks, benefits and processes for both living and deceased donor transplantation. The program also teaches key communication skills needed to effectively initiate and manage conversations about transplantation.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: Baseline (upon enrollment); 1 month post; 3 months post
2 self-report items: whether transplantation was discussed (yes/no) and the number of discussions held
Time frame: Upon enrollment (baseline); 1 month post; 2 months post
15 True/False Questions
Time frame: Upon enrollment (baseline); 1 month post; 3 months post
3-item, 7-point Likert-type scale
Virginia Commonwealth University
Other
Communicating About Choices in Transplantation (COACH)
Acronym: COACH
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05983770
Chronic Disease, Disease Attributes
Los Angeles, California, United States
View Trial DetailsNCT07716436
Behavior, Chronic Disease
Tanta, Gharbia Governorate, Egypt
View Trial DetailsNCT07518628
Behavior, Chronic Disease
Nicosia, Cyprus
View Trial DetailsNCT05309785
CKD Stage 4, CKD Stage 5
Montreal, Quebec, Canada
View Trial Details